These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6228468)
1. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982). Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine: simultaneous passive and active immunization. Indications in pre- and post-exposure. Goudeau A; Dubois F; Geslin N; Pierre D Dev Biol Stand; 1983; 54():259-66. PubMed ID: 6228467 [TBL] [Abstract][Full Text] [Related]
3. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150 [TBL] [Abstract][Full Text] [Related]
4. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. Jafarzadeh A; Montazerifar SJ J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B in haemodialysis: vaccination against HBS antigen. Crosnier J Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150 [TBL] [Abstract][Full Text] [Related]
6. The use of hepatitis B vaccine as booster for donors immune to HBV for the production of hepatitis B immunoglobulin (HBIG). Couroucé AM; Bouchardeau F; Le Marrec N; Boulard G; Soulier JP Dev Biol Stand; 1983; 54():333-40. PubMed ID: 6228472 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands. Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459 [TBL] [Abstract][Full Text] [Related]
8. [Hepatitis B vaccination]. Descoeudres C Schweiz Med Wochenschr; 1984 Apr; 114(15):498-505. PubMed ID: 6729415 [TBL] [Abstract][Full Text] [Related]
9. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627 [TBL] [Abstract][Full Text] [Related]
10. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization]. Li H; Li R; Liao S; Yang J; Zeng X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735 [TBL] [Abstract][Full Text] [Related]
11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers. Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152 [TBL] [Abstract][Full Text] [Related]
13. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients. Scheiermann N; Kuwert EK Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers. Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463 [TBL] [Abstract][Full Text] [Related]
15. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine. Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191 [TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. Lu CY; Ni YH; Chiang BL; Chen PJ; Chang MH; Chang LY; Su IJ; Kuo HS; Huang LM; Chen DS; Lee CY J Infect Dis; 2008 May; 197(10):1419-26. PubMed ID: 18444799 [TBL] [Abstract][Full Text] [Related]
17. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine]. Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590 [TBL] [Abstract][Full Text] [Related]
18. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503 [TBL] [Abstract][Full Text] [Related]
19. Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine. Legler K; Strohmeyer H; Ritter S; Gerlich WH; Thomssen R Dev Biol Stand; 1983; 54():179-89. PubMed ID: 6228457 [TBL] [Abstract][Full Text] [Related]
20. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands. Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]